APTN · OTC · SIC 2836: Biological Products, (No Diagnostic Substances)
19
SEC Filings
$6
Close 2026-05-27
Business Summary
PART I . Our Company The Companys objective is to develop and commercialize products utilizing novel technology that enhances the delivery of drugs and other compounds to the brain and other tissues for a variety of indications. Our novel technology was originally developed by researchers in the Department of Neurosurgery at Duke University and licensed by us in 2023. Our website address is www.adaptinbio.com and we can be contacted at info@adaptinbio.com. Information contained on, or that can b...